Foquest Capsule (2018-08-08)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 135570 | - Recalling Firm
- Purdue Pharma
- 575 Granite Court
- Pickering
- L1W 3W8
- Ontario
- CANADA
- Marketing Authorization Holder
- Purdue Pharma
- 575 Granite Court
- Pickering
- L1W 3W8
- Ontario
- CANADA
| Foquest Capsule | Capsule (Controlled Release) | DIN 02470322 | Methylphenidate Hydrochloride 55mg |
Recalled Products
Foquest Capsule
Affected lot had an out of specification result for potency during shelf life testing.